"The normal critique of socialized medicine is to point out that people have to wait a long time for . . . treatments in places like Britain. And that's certainly a valid critique . . . .
The key point, though, is that these treatments didn't just come out of the blue. They were developed by drug companies and device makers who thought they had a good market for things that would make people feel better.
But under a national healthcare plan, the "market" will consist of whatever the bureaucrats are willing to buy. That means treatment for politically stylish diseases will get some money, but otherwise the main concern will be cost-control. More treatments, to bureaucrats, mean more costs . . . .It's ironic that the same Democrats who were pushing the medical prospects for stem-cell research during the last election are now pushing a program that will make such progress far less likely."
Or maybe it's just flat-out ignorance.
Either way, it would not be out of character for these types, would it?